Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in DHR — Danaher Corp /De/

CIK 1729829 LONDON, X0
Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$255,762,057
+$204,435,675 QoQ
Shares Held
1,348,956
+501.6% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$3,507,600
CallShares
18,500
PutValue
$12,854,880
PutShares
67,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $924,641,036 across 18 Diagnostics & Research names. DHR ranks #2 (27.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 2,280,319 $259,910,759
2 DHR
Danaher Corp /De/
This page 		1,348,956 $255,762,057
3 DGX
Quest Diagnostics Inc
 734,714 $143,989,249
4 TMO
Thermo Fisher Scientific Inc.
 188,774 $92,788,084
5 NTRA
Natera, Inc.
 306,300 $61,256,937
6 IDXX
Idexx Laboratories Inc /De
 85,650 $48,125,878
7 CSTL
Castle Biosciences Inc
 559,583 $13,737,762
8 QGEN
Qiagen N.V.
 313,960 $12,570,958

All Filings in DHR

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $255,762,057 1,348,956
2026-03-31 $3,507,600 18,500
2026-03-31 $12,854,880 67,800
2025-12-31 $10,576,104 46,200
2025-12-31 $3,021,744 13,200
2025-12-31 $51,326,382 224,211
2025-09-30 $151,299,938 763,139
2025-09-30 $13,382,550 67,500
2025-09-30 $11,657,688 58,800
2025-06-30 $227,417,529 1,151,248
2025-06-30 $5,708,906 28,900
2025-06-30 $20,425,636 103,400
2025-03-31 $4,653,500 22,700
2025-03-31 $197,512,170 963,474
2025-03-31 $34,419,500 167,900
2024-12-31 $3,580,980 15,600
2024-12-31 $224,539,612 978,173
2024-12-31 $43,316,085 188,700
2024-09-30 $12,983,534 46,700
2024-09-30 $117,055,038 421,031
2024-09-30 $13,372,762 48,100
2024-06-30 $7,845,290 31,400
2024-06-30 $2,072,505 8,295
2024-03-31 $116,565,550 466,785
2024-03-31 $24,073,008 96,400
2024-03-31 $524,412 2,100
2023-12-31 $347,010 1,500
2023-12-31 $16,563,944 71,600
2023-12-31 $121,397,746 524,759
2023-09-30 $5,982,552 27,200
2023-09-30 $1,368,728 6,223
2023-06-30 $12,723,406 59,800
2023-06-30 $85,106 400
2023-03-31 $105,249,706 471,043
2022-12-31 $6,344,431 26,963
2021-12-31 $11,905,318 40,817
2021-09-30 $28,430,321 105,339
2021-06-30 $12,747,337 53,581
2021-03-31 $1,116,420 5,595
2020-12-31 $11,059,537 56,159
2020-09-30 $340,748 1,785
2020-06-30 $663,269 4,231

Report a Problem

Category
Description
Email (optional, for follow-up)